In treating estrogen receptor-positive breast cancer in postmenopausal women, Aromatase Inhibitors (AIs) prove effective. Yet, these treatments commonly bring along side effects that significantly impact patients’ quality of life. A review by Raptopoulos and Constantinou (2020) summarises evidence from recent studies that delves into the role of exercise interventions in mitigating the side effects faced by breast cancer patients undergoing AI treatment.

Studies reveal that exercise interventions not only improve body composition but also alleviate AIIA (Aromatase Inhibitor-Induced Arthralgia) and enhance the overall quality of life for breast cancer patients. Longitudinal exercise programs show promise in further enhancing the wellbeing of those on AI treatment.

Future research aims to delve deeper into the effects of exercise on addressing depression, cognitive decline, and cardiotoxicity among postmenopausal breast cancer patients on AI treatment. Understanding the motivational aspects to keep survivors engaged in these exercise programs is also a key focus for upcoming studies.